Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | KDM1A | O60341 | 2/20 | 0.38 |
| ▸ | SMO | Q99835 | 3/20 | 0.37 |
| ▸ | MC2R | Q01718 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | P2RY12 | Q9H244 | 5/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | CETP | P11597 | 1/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21980897 | 0.80 | GPR119 (0.47) | ALDH1A1KDM4ENPSR1KCNH2SYK | |
| SCHEMBL22035964 | 0.78 | KCNH2 (0.48) | ALDH1A1KDM4ENPSR1KDM1AKCNH2 | |
| SCHEMBL21980906 | 0.78 | ALDH1A1 (0.46) | ALDH1A1KDM4ENPSR1KCNH2P2RY12 | |
| SCHEMBL22036424 | 0.78 | ALDH1A1 (0.54) | ALDH1A1KDM4ENPSR1P2RY12 | |
| SCHEMBL22172248 | 0.77 | ALDH1A1 (0.46) | ALDH1A1KDM4ENPSR1KCNH2P2RY12 | |
| SCHEMBL22036425 | 0.77 | ALDH1A1 (0.42) | ALDH1A1KDM4ENPSR1KCNH2SYK | |
| SCHEMBL21980910 | 0.75 | XDH (0.46) | ALDH1A1KDM4EKDM1AXDH | |
| SCHEMBL31075053 | 0.73 | ENPP2 (0.44) | ALDH1A1KDM4ENPSR1KDM1ASYK | |
| SCHEMBL30918300 | 0.73 | ALDH1A1 (0.41) | ALDH1A1KDM4ENPSR1KDM1AMC2R | |
| SCHEMBL30918298 | 0.73 | ALDH1A1 (0.40) | ALDH1A1KDM4ENPSR1KDM1ASYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3889137-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2021-10-06 | — | — | EP | disclosed |
| EP-3674291-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-20200163336-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2020-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200163336-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | H1-10, TAAR1, C5 | ALDH1A1 3511/4885KDM4E 660/4885NPSR1 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.